Lund University Hospital — Clinical Trial Site

21 Registered trials

11 Currently recruiting

Organisation

Lund University Hospital

Location

Lund, Sweden

Identifier

ORG-100009989

Address

Getingevaegen 4, 222 42, Sweden

Departments

Cardiology
Department of Hematology
Department of Hematology and Coagulation
Department of Hematology, Oncology and Radiation physics
Department of Infectious Diseases
Department of Oncology
Department of Respiratory Medicine
Department of surgery
Dept Obstetrics and Gynecology
dept of Ob/gyn
Dept. of Hematology, Oncology and Radiation physics
Hematology
Hjärtmottagningen
Oncology
Pediatric Surgery
Reumatologi
Thoraxkirurgi

Clinical trials at this site (21)

Search interface

Immediate insertion of intrauterine contraception after medical abortion Pending

2024-517082-16-01 Post medical abortion contraception 5
Rituximab as therapy for autoantibody mediated fibromyalgia (RAFT) - proof of concept Pending

2025-523465-21-00 Fibromyalgia 5
A randomized study in testicular cancer without metastasis, comparing two different types of chemotherapy used to reduce the risk of relapse Recruiting

2024-518399-29-00 Testicular cancer 5 2024-12-27
This is a first in human study, in patients with severe bleeding disorder (hemophilia A), who has developed inhibitory antibodies against co… Recruiting

2022-502030-12-01 Treatment of patients with Hemophilia A who have develo 1 2022-10-13
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax P… Recruiting

2024-517131-52-00 Relapsed/Refractory Chronic Lymphocytic Leukemia/Small 5 2025-11-03
Optimizing endocrine treatment > 5 years after surgery for breast cancer patients: a registry-based randomized clinical trial Recruiting

2023-506135-14-00 Breast cancer 11 2025-09-10
VEX-AZA: Treating VEXAS Syndrome with Azacitidine. A Single-Arm, Multicenter Phase II Study on the Efficacy and Safety of Azacitidine in Pat… Recruiting

2024-510715-30-00 VEXAS 4 2024-09-26
PHASE II STUDY OF AZACITIDINE IN COMBINATION WITH LOW DOSE INTENSITY VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH INTEGRATION OF … Recruiting

2023-510415-19-00 Acute Myeloid Leukemia 4 2024-08-28
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock f… Recruiting

2024-510892-40-00 Acute myocardial infarction complicated by cardiogenic 6 2024-02-29
Can patients with atrial fibrillation discontinue anticoagulant therapy after cardiac surgery: The ATLAAC trial Recruiting

2022-502986-92-00 Atrial fibrillation 6 2024-02-27
STEPS-EA trial Recruiting

2023-504905-36-00 Strictures after esophageal atresia repair 11 2024-01-11
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting

2023-505483-11-00 Brain abscess 6 2021-05-02
Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to… Recruiting

2023-509847-29-00 Advanced solid tumors 7 2020-04-09
DAPARHT: DAPAgliflozin for Renal protection in Heart Transplant recipients Ended

2023-506486-60-01 Heart transplant 5 2022-04-26
Is there a survival benefit of administering thoracic radiotherapy concurrently with immunnotherapy and chemotherapy for patients with exten… Ended

2023-505514-15-00 Small-cell lung cancer, extensive stage 5 2022-01-11
Acalabrutinib and rituximab in elderly patients with untreated mantle cell lymphoma (ALTAMIRA) Ended

2023-509864-96-00 Mantle Cell Lymphoma (MCL) 4 2021-12-07
A randomized double blind, multicenter trial to assess time-interval between cytoreductive surgery and adjuvant chemotherapy after administr… Ended

2023-507732-20-00 Advanced epithelial ovarian cancer stage III-IV 5 2019-11-29
A STUDY OF EFFICACY AND SAFETY OF LONG-ACTING LOW DOSE ROPEGINTERFERON IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH BOSUTINIB FROM… Ended

2024-517417-32-00 CHRONIC MYELOID LEUKEMIA 4 2018-11-22
A randomized phase II study comparing atezolizumab after concurrent chemoradiotherapy with chemoradiotherapy alone in limited disease small-… Ended

2024-515755-37-00 Limited disease small-cell lung cancer 4 2018-07-31
Lidocaine in Liver Surgery Ended

2023-508173-90-00 Patients with liver tumours that have liver surgery per 10 2021-11-15
Intermittent ibrutinib in chronic lymphocytic leukemia Ended

2023-508638-32-00 Chronic lymphocytic leukemia 3 2018-04-06